Skip to main content
NeuronFeed
Home Investors Aisling Capital

Aisling Capital

Active VC
Portfolio Active
1
Latest Treeline Biosciences
Deal flow
$200M
1 round
Unicorns
0
≥ $1B valuation
Founded
—
Latest
Aug 2025
Treeline Biosciences

About Aisling Capital

Venture capital firm tracking 1 AI investment, with focus on Drug Discovery and US startups. Total tracked deal flow: $200M.

Sector focus

💊 Drug Discovery 1
🩺 AI Medical 1

Geographic focus

US 1

Portfolio

1

Treeline Biosciences

Computational and experimental drug discovery for hard-to-drug cancer targets

Co-investors

8

Exor

1 shared

Rock Springs Capital

1 shared

Fidelity Investments

1 shared

Casdin Capital

1 shared

Ajax Health

1 shared

KKR

1 shared

OrbiMed

1 shared

ARCH Venture Partners

1 shared

Recent rounds

1
Aug 21, 2025 Series A $200M Treeline Biosciences